Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)-Reference-Cited by-同舟云学术

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)

Published:2012-04 Issue:1 Volume:125 Page:175-180
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Monsonego Joseph,Hudgens Michael G.,Zerat Laurent,Zerat Jean-Claude,Syrjänen Kari,Smith Jennifer S.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference43 articles.

1. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet];Ferlay,2010

2. Report on consensus conference on cervical cancer screening and management;Miller;Int J Cancer,2000

3. Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: experience from the New Independent States of the former Soviet Union cohort study;Syrjänen;Acta Cytol,2009

4. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial;Solomon;J Natl Cancer Inst,2001

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up;Cancer Cytopathology;2024-08-19

2. HPV Testing and its Role in Cervical Cancer Screening;Clinical Obstetrics & Gynecology;2023-08-03

3. Molecular diagnostics of infectious disease: Detection and characterization of microbial agents in cytology samples;Diagnostic Cytopathology;2022-10-20

4. Performance of the Human Papillomavirus E6/E7 mRNA Assay in the Primary Screening of Cervical Cancer: Opportunistic Screening in Fujian, China;International Journal of Women's Health;2022-10

5. Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China;Frontiers in Cellular and Infection Microbiology;2022-08-29